Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease

被引:22
|
作者
Wajner, Alessandro
Michelin, Kristiane
Burin, Maira G.
Pires, Ricardo F.
Pereira, Maria Luiza S.
Giugliani, Roberto
Coelho, Janice C. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Genet IB, Porto Alegre, RS, Brazil
关键词
chitotriosidase; Gaucher disease; GM1-gangliosidosis; Krabbe disease; enzyme kinetics; lysosomal storage diseases;
D O I
10.1016/j.clinbiochem.2006.12.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The aim of the present work was to establish the range of chitotriosidase (CT) activity in normal individuals (controls), patients with Gaucher disease (GD), GM1-gangliosidosis (GM1), Krabbe disease (KD) and heterozygotes for Gaucher disease (HG). The kinetics of the enzyme in the five groups was also investigated. Design and methods: Plasma CT activity, as well as K-m, V-max, optimum pH and thermal stability of the enzyme was determined in plasma of controls, GM I, KD, GD and HG subjects. Results: CT activity in GD, GM1 and KD patients was, respectively, around 600-fold, 15-fold and 12-fold greater than in normal individuals. There was no significant difference between CT activity in the HG and the control group. We also demonstrated that all CT kinetic parameters evaluated (optimum pH, K-m, thermal stability) in plasma of GD, KD and GM1 patients were significantly different from those of normal individuals. Regarding to thermal stability, our results show that CT activity in the Control group was more stable than in the other groups. Conclusions: Based on the differences found in the biochemical parameters studied, we presume that the parameters analyzed may be useful in the diagnosis of the Lysosomal Storage Diseases. (c) 2007 Published by The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 50 条
  • [21] Identification of chitotriosidase isoforms in plasma of Gaucher disease patients by two dimensional gel electrophoresis.
    Quintana, L
    Monasterio, A
    Escuredo, K
    del Amo, J
    Alfonso, P
    Elortza, F
    Santacruz, S
    Simon, L
    Martinez, A
    Pocovi, M
    Castrillo, JL
    Giraldo, P
    BLOOD, 2005, 106 (11) : 50B - 50B
  • [22] Switching between ERT and SRT in patients with Gaucher disease: Data from the Gaucher Outcome Survey (GOS)
    Hughes, Derralynn
    Deegan, Patrick
    Lau, Heather
    Gadir, Noga
    Botha, Jaco
    Revel-Vilk, Shoshana
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S50 - S50
  • [23] Treatment patterns from 647 patients with Gaucher disease: An analysis from the Gaucher Outcome Survey
    Deegan, P.
    Fernandez-Sasso, D.
    Giraldo, P.
    Lau, H.
    Panahloo, Z.
    Zimran, A.
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 218 - 225
  • [24] Treatment patterns from 647 patients with Gaucher disease: an analysis from the Gaucher Outcome Survey
    Deegan, Patrick
    Fernandez-Sasso, Diego
    Giraldo, Pilar
    Lau, Heather
    Panahloo, Zoya
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S40 - S41
  • [25] IDENTIFYING THE RISK OF COMPLICATIONS IN PATIENTS WITH GAUCHER DISEASE: A MACHINE LEARNING ANALYSIS FROM THE SPANISH GAUCHER DISEASE REGISTRY
    Andrade-Campos, Marcio
    Lopez, de Frutos Laura
    Serrano, Gonzalo Irene
    Medrano, Engay Blanca
    Roca, Espiau Mercedes
    Gomez, Barrera Beatriz
    Perez-Heredia, Jorge
    Iniguez, David
    Giraldo, Castellano Pilar
    HAEMATOLOGICA, 2020, 105 : 133 - 134
  • [26] Prevalence of cancer among 867 patients with Gaucher disease from the SZMC Gaucher unit
    Istaiti, Majdolen J.
    Dinur, Tama
    Revel-Vilk, Shoshana
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 67 - 67
  • [27] Bony Symptoms and Vertebral Fractures in Gaucher Disease Type 1. Data from the 105 Patients of the French Observatoire on Gaucher Disease
    Javier, R.
    Janssaud, R.
    Rose, C.
    Cherin, P.
    Noel, E.
    Serratrice, C. de Roux
    Dobbelaere, D.
    Hartmann, A.
    Hachulla, E.
    Grosbois, B.
    Roux, C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S221 - S221
  • [28] Characteristics and management of US pediatric patients with Gaucher disease from the Gaucher Outcome Survey
    Goker-Alpan, Ozlem
    Burrow, Andrew
    Enns, Gregory M.
    Ficicioglu, Can
    Kishnani, Priya S.
    Ortiz, Damara
    Prada, Carlos E.
    Vats, Divya
    Weinreb, Neal J.
    Robinson, Ian
    Pathak, Ravi R.
    Wright, Ekaterina
    Botha, Jaco
    Wilcox, William R.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [29] Chitotriosidase genotype and plasma activity in patients with type 1 Gaucher's disease and their relatives (carriers and non-carriers)
    Giraldo, P
    Cenarro, A
    Alfonso, P
    Pérez-Calvo, JI
    Rubio-Félix, D
    Giralt, M
    Pocovi, M
    HAEMATOLOGICA, 2001, 86 (09) : 977 - 984
  • [30] Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases
    Sanchez-Fernandez, Elena M.
    Garcia Fernandez, Jose M.
    Ortiz Mellet, Carmen
    CHEMICAL COMMUNICATIONS, 2016, 52 (32) : 5497 - 5515